{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T01:20:30Z","timestamp":1794100830155,"version":"4.8.0"},"reference-count":72,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>This review is to provide an update on the current understanding of rheumatoid arthritis (RA) development related to disease development prior to the onset clinically apparent synovitis (i.e. Pre-RA), and opportunities for disease prevention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>A growing number of studies have demonstrated that serum elevations of autoantibodies rheumatoid factor, antibodies to citrullinated protein\/peptide antigens (ACPAs) and antibodies to other posttranslationally modified proteins (e.g. carbamylated proteins) are highly predictive of future development of inflammatory arthritis\/RA during a period that can be termed Pre-RA. Other factors including genetic, environmental, symptoms and imaging findings can also enhance prediction. Moreover, several novel biomarkers and changes in autoantibodies (e.g. glycosylation of variable domains) have been identified in Pre-RA. There has also been growing evidence that initiation and propagation of RA-related autoimmunity during the Pre-RA phase may be related to mucosal processes. The discovery of Pre-RA has also underpinned the development of several clinical prevention trials in RA; specifically, the PRAIRI study demonstrated that a single dose of rituximab can delay the onset of clinically apparent IA in at-risk individuals. Additional studies are evaluating the ability of drugs including abatacept, hydroxychloroquine and methotrexate to prevent or delay future RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The results from ongoing natural history and prevention trials in RA should further inform several critical issues in RA prevention including identification and enrolment of individuals at high-risk of imminent RA, the efficacy, safety and cost-effectiveness of prevention, and potentially the identification of new targets for prevention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/bor.0000000000000708","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:28:25Z","timestamp":1585009705000},"page":"289-296","source":"Crossref","is-referenced-by-count":64,"title":["Preclinical rheumatoid arthritis and rheumatoid arthritis prevention"],"prefix":"10.1097","volume":"32","author":[{"given":"H. Karl","family":"Greenblatt","sequence":"first","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyoun-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"},{"name":"Department of Rheumatology, Ajou University School of Medicine, Suwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah F.","family":"Bettner","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Deane","sequence":"additional","affiliation":[{"name":"University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230829","doi-asserted-by":"crossref","first-page":"18001","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20230829","first-page":"613","article-title":"Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multidimensional remission criteria and patient reported outcomes","volume":"59","author":"Gul","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"R3-20230829","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/acr.23518","article-title":"2015 American College of Rheumatology Workforce Study: supply and demand projections of Adult Rheumatology Workforce, 2015\u20132030","volume":"70","author":"Battafarano","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R4-20230829","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3389\/fphar.2018.01070","article-title":"Comparative price analysis of biological products for treatment of rheumatoid arthritis","volume":"9","author":"Manova","year":"2018","journal-title":"Front Pharmacol"},{"key":"R5-20230829","article-title":"Rheumatoid arthritis patient's journey: delay in diagnosis and treatment","author":"Rosa","year":"2019","journal-title":"J Clin Rheumatol"},{"key":"R6-20230829","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","article-title":"EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis","volume":"71","author":"Gerlag","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"R7-20230829","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R8-20230829","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R9-20230829","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11926-011-0193-7","article-title":"Antibodies to citrullinated protein antigens (ACPAs): clinical and pathophysiologic significance","volume":"13","author":"Demoruelle","year":"2011","journal-title":"Curr Rheumatol Rep"},{"key":"R10-20230829","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","article-title":"The extent of the anticitrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia","volume":"70","author":"van de Stadt","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R11-20230829","doi-asserted-by":"crossref","first-page":"e35296","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the preclinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"R12-20230829","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/annrheumdis-2016-209154","article-title":"Omega-3 fatty acids are associated with a lower prevalence of autoantibodies in shared epitope-positive subjects at risk for rheumatoid arthritis","volume":"76","author":"Gan","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R13-20230829","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anticarbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R14-20230829","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.intimp.2018.01.022","article-title":"Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions","volume":"56","author":"Mikuls","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"R15-20230829","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/art.27533","article-title":"Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis","volume":"62","author":"Ercan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R16-20230829","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-linked glycans in the variable domain of IgG anti-citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R17-20230829","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fmed.2018.00219","article-title":"Survivin measurement improves clinical prediction of transition from arthralgia to RA-biomarkers to improve clinical sensitivity of transition from arthralgia to RA","volume":"5","author":"Erlandsson","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R18-20230829","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13075-016-0975-4","article-title":"A prospective cohort study of 14-3-3eta in ACPA and\/or RF-positive patients with arthralgia","volume":"18","author":"van Beers-Tas","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R19-20230829","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1136\/annrheumdis-2017-211351","article-title":"Dominant B cell receptor clones in peripheral blood predict onset of arthritis in individuals at risk for rheumatoid arthritis","volume":"76","author":"Tak","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R20-20230829","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1136\/annrheumdis-2015-207991","article-title":"T cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individuals","volume":"75","author":"Hunt","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R21-20230829","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1093\/rheumatology\/kex360","article-title":"The association between omega-3 fatty acid biomarkers and inflammatory arthritis in an anticitrullinated protein antibody positive population","volume":"56","author":"Gan","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20230829","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.25036","article-title":"Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients","volume":"62","author":"Snir","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R23-20230829","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.30655","article-title":"Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study","volume":"64","author":"Gent","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R24-20230829","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/ard.2010.139527","article-title":"Different stages of rheumatoid arthritis: features of the synovium in the preclinical phase","volume":"70","author":"van de Sande","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R25-20230829","doi-asserted-by":"crossref","first-page":"R98","DOI":"10.1186\/ar3028","article-title":"The value of ultrasonography in predicting arthritis in auto-antibody positive arthralgia patients: a prospective cohort study","volume":"12","author":"van de Stadt","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"R26-20230829","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R27-20230829","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.40401","article-title":"Antibody responses to citrullinated and noncitrullinated antigens in the sputum of subjects with rheumatoid arthritis and subjects at risk for development of rheumatoid arthritis","volume":"70","author":"Demoruelle","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R28-20230829","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.34595","article-title":"Porphyromonas gingivalis and disease-related autoantibodies in individuals at increased risk of rheumatoid arthritis","volume":"64","author":"Mikuls","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R29-20230829","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/art.34539","article-title":"Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis","volume":"64","author":"Scher","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R30-20230829","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol Rev"},{"key":"R31-20230829","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jre.12002","article-title":"Expression of peptidylarginine deiminase-2 and -4, citrullinated proteins and anticitrullinated protein antibodies in human gingiva","volume":"48","author":"Harvey","year":"2013","journal-title":"J Periodontal Res"},{"key":"R32-20230829","doi-asserted-by":"crossref","first-page":"369ra176","DOI":"10.1126\/scitranslmed.aaj1921","article-title":"Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis","volume":"8","author":"Konig","year":"2016","journal-title":"Sci Transl Med"},{"key":"R33-20230829","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/annrheumdis-2018-213697","article-title":"Porphyromonas gingivalis experimentally induces periodontis and an anti-CCP2-associated arthritis in the rat","volume":"78","author":"Courbon","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R34-20230829","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1902\/jop.2015.150455","article-title":"Periodontal disease in individuals with a genetic risk of developing arthritis and early rheumatoid arthritis: a cross-sectional study","volume":"87","author":"Bello-Gualtero","year":"2016","journal-title":"J Periodontol"},{"key":"R35-20230829","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/jcpe.13117","article-title":"Periodontal status correlates with anticitrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis","volume":"46","author":"Loutan","year":"2019","journal-title":"J Clin Periodontol"},{"key":"R36-20230829","doi-asserted-by":"crossref","first-page":"e195394","DOI":"10.1001\/jamanetworkopen.2019.5394","article-title":"Prevalence of periodontal disease and periodontopathic bacteria in anti-cyclic citrullinated protein antibody-positive at-risk adults without arthritis","volume":"2","author":"Mankia","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R37-20230829","doi-asserted-by":"crossref","first-page":"e01202","DOI":"10.7554\/eLife.01202","article-title":"Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis","volume":"2","author":"Scher","year":"2013","journal-title":"Elife"},{"key":"R38-20230829","first-page":"1500","article-title":"Fecal microbiota in early rheumatoid arthritis","volume":"35","author":"Vaahtovuo","year":"2008","journal-title":"J Rheumatol"},{"key":"R39-20230829","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00284-013-0338-1","article-title":"Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis","volume":"67","author":"Liu","year":"2013","journal-title":"Curr Microbiol"},{"key":"R40-20230829","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/annrheumdis-2018-214514","article-title":"Prevotella copri in individuals at risk for rheumatoid arthritis","volume":"78","author":"Alpizar-Rodriguez","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R41-20230829","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/art.41091","article-title":"Timing of elevations of autoantibody isotypes in rheumatoid arthritis prior to disease diagnosis","volume":"72","author":"Kelmenson","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"R42-20230829","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.3389\/fimmu.2018.02771","article-title":"Prevalence and incidence of upper respiratory tract infection events are elevated prior to the development of rheumatoid arthritis in first-degree relatives","volume":"9","author":"Arleevskaya","year":"2018","journal-title":"Front Immunol"},{"key":"R43-20230829","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.40490","article-title":"Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation","volume":"70","author":"Jubair","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R44-20230829","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/annrheumdis-2014-205227","article-title":"Predicting the development of clinical arthritis in anti-CCP positive individuals with nonspecific musculoskeletal symptoms: a prospective observational cohort study","volume":"74","author":"Rakieh","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R45-20230829","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/annrheumdis-2012-202127","article-title":"A prediction rule for the development of arthritis in seropositive arthralgia patients","volume":"72","author":"van de Stadt","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R46-20230829","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.clinthera.2019.04.017","article-title":"Predicting rheumatoid arthritis in at-risk individuals","volume":"41","author":"van Boheemen","year":"2019","journal-title":"Clin Ther"},{"key":"R47-20230829","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1002\/art.39297","article-title":"Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease","volume":"67","author":"Ramos-Remus","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R48-20230829","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1136\/annrheumdis-2012-202254","article-title":"Smoking and overweight determine the likelihood of developing rheumatoid arthritis","volume":"72","author":"de Hair","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"R49-20230829","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1136\/annrheumdis-2018-214331","article-title":"MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis","volume":"78","author":"Mankia","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R50-20230829","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/rheumatology\/key220","article-title":"Is joint pain in patients with arthralgia suspicious for progression to rheumatoid arthritis explained by subclinical inflammation? A cross-sectional MRI study","volume":"58","author":"Burgers","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R51-20230829","article-title":"Imaging in the preclinical phases of rheumatoid arthritis","author":"Zabotti","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"R52-20230829","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/rheumatology\/kex235","article-title":"Using a reference when defining an abnormal MRI reduces false-positive MRI results: a longitudinal study in two cohorts at risk for rheumatoid arthritis","volume":"56","author":"Boer","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R53-20230829","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/art.40880","article-title":"A prospective study of the development of inflammatory arthritis in the family members of indigenous North American people with rheumatoid arthritis","volume":"71","author":"Tanner","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R54-20230829","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3899\/jrheum.120736","article-title":"Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes","volume":"40","author":"Barra","year":"2013","journal-title":"J Rheumatol"},{"key":"R55-20230829","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/rheumatology\/keq190","article-title":"Lack of seroconversion of rheumatoid factor and anticyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review","volume":"50","author":"Barra","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"R56-20230829","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/annrheumdis-2016-209846","article-title":"EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"76","author":"van Steenbergen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R57-20230829","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1093\/rheumatology\/kex324","article-title":"Validation of the EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis","volume":"56","author":"Burgers","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R58-20230829","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/annrheumdis-2017-212763","article-title":"Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study","volume":"78","author":"Gerlag","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"R60-20230829","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13063-019-3403-7","article-title":"Arthritis prevention in the preclinical phase of RA with abatacept (the APIPPRA study): a multicentre, randomised, double-blind, parallel-group, placebo-controlled clinical trial protocol","volume":"20","author":"Al-Laith","year":"2019","journal-title":"Trials"},{"key":"R63-20230829","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1056\/NEJMoa1902226","article-title":"Type 1 Diabetes TrialNet Study G. Teplizumab in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"R64-20230829","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.2337\/db18-0065","article-title":"Strength in numbers: opportunities for enhancing the development of effective treatments for type 1 diabetes: the TrialNet experience","volume":"67","author":"Greenbaum","year":"2018","journal-title":"Diabetes"},{"key":"R65-20230829","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11926-016-0598-4","article-title":"Preventive treatments for rheumatoid arthritis: issues regarding patient preferences","volume":"18","author":"Finckh","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"R66-20230829","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.clinthera.2019.04.015","article-title":"Preferences of patients and at-risk individuals for preventive approaches to rheumatoid arthritis","volume":"41","author":"Falahee","year":"2019","journal-title":"Clin Ther"},{"key":"R67-20230829","doi-asserted-by":"crossref","first-page":"e0216075","DOI":"10.1371\/journal.pone.0216075","article-title":"Preventing rheumatoid arthritis: preferences for and predicted uptake of preventive treatments among high risk individuals","volume":"14","author":"Harrison","year":"2019","journal-title":"PLoS One"},{"key":"R68-20230829","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2017.08.003","article-title":"Genetic and environmental risk factors for rheumatoid arthritis","volume":"31","author":"Deane","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R69-20230829","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/rheumatology\/kev347","article-title":"Towards prevention of autoantibody-positive rheumatoid arthritis: from lifestyle modification to preventive treatment","volume":"55","author":"Gerlag","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"R70-20230829","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.clinthera.2019.04.021","article-title":"Potential of lifestyle changes for reducing the risk of developing rheumatoid arthritis: is an ounce of prevention worth a pound of cure?","volume":"41","author":"Zaccardelli","year":"2019","journal-title":"Clin Ther"},{"key":"R71-20230829","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/acr.23411","article-title":"Disclosure of personalized rheumatoid arthritis risk using genetics, biomarkers, and lifestyle factors to motivate health behavior improvements: a randomized controlled trial","volume":"70","author":"Sparks","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R72-20230829","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cct.2014.08.007","article-title":"Personalized Risk Estimator for Rheumatoid Arthritis (PRE-RA) Family Study: rationale and design for a randomized controlled trial evaluating rheumatoid arthritis risk education to first-degree relatives","volume":"39","author":"Sparks","year":"2014","journal-title":"Contemp Clin Trials"},{"key":"R73-20230829","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/art.20853","article-title":"Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study","volume":"52","author":"Maradit-Kremers","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R74-20230829","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1017\/S2045796017000579","article-title":"Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease","volume":"28","author":"Marrie","year":"2019","journal-title":"Epidemiol Psychiatr Sci"},{"key":"R75-20230829","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/annrheumdis-2018-213700","article-title":"Overdiagnosis and overtreatment in rheumatology: a little caution is in order","volume":"77","author":"Landewe","year":"2018","journal-title":"Ann Rheum Dis"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T20:54:03Z","timestamp":1695934443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000708","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}